| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110045009 Cell Permeable Peptide |
| 02/24/2011 | US20110044989 Zona Pellucida Binding Peptides, Expression Vectors, Compositions, and Methods for Species Specific Immunocontraception of Animals |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/24/2011 | DE102009037551A1 Cyclosporinderivate Cyclosporin derivatives |
| 02/24/2011 | CA2771429A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287175A2 Novel chemokine binding peptides capable of modulating the biological activity of chemokines |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2286226A2 Serum markers for type ii diabetes mellitus |
| 02/23/2011 | EP2285396A1 Novel dual targeting antitumoural conjugates |
| 02/23/2011 | EP2285395A2 Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders |
| 02/23/2011 | EP1520174B1 Diagnostic method for determination of M. tuberculosis |
| 02/23/2011 | CN101981187A Partial peptide of Survivin presented on MHC class II molecule and use thereof |
| 02/23/2011 | CN101981050A 新的凝血因子抑制剂 New clotting factor inhibitors |
| 02/23/2011 | CN101980721A Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/23/2011 | CN101979413A Peptide purification by means of metal ion affinity chromatography |
| 02/23/2011 | CN101979405A Immune dominant HLA-A3 super-type restrictive CTL epitope of hepatitis B virus core antigen and identification method and application thereof |
| 02/23/2011 | CN101979404A Conserved neutralizing epitope mimic peptide of H5 subtype avian influenza viruses and use thereof |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/22/2011 | US7894999 Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds |
| 02/22/2011 | US7892834 Cellular signal-responsive gene transcriptional regulation system |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892775 Fluorescence assay for kinase activity |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892557 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892529 Peptides for active anti-cytokine immunization |
| 02/22/2011 | CA2540678C Pharmaceutical compositions for prevention of overdose or abuse |
| 02/22/2011 | CA2435877C Prevention of diabetes by administration of gnrh antagonists |
| 02/22/2011 | CA2329772C Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 02/17/2011 | WO2011019839A2 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 02/17/2011 | WO2011019285A1 Separation and/or purification of pneumocandin b0 from c0 |
| 02/17/2011 | WO2011019123A1 Novel peptide and use thereof |
| 02/17/2011 | WO2011018745A1 Chromatographic processes and purified compounds thereof |
| 02/17/2011 | WO2010096603A3 Cancer-targeting peptides and uses thereof in cancer therapy |
| 02/17/2011 | US20110040087 Peptide turn mimetics |
| 02/17/2011 | US20110040072 Mono and di-substituted oxycodone compounds and compositions |
| 02/17/2011 | US20110040071 Protein Kinase-Inducible Domains |
| 02/17/2011 | US20110039792 Selective Targeting Agents for Mitochondria |
| 02/17/2011 | US20110039770 Inhibitors of protein kinase c isoforms and uses thereof |
| 02/17/2011 | US20110039760 Multimeric forms of antimicrobial peptides |
| 02/17/2011 | US20110039331 Tag peptide and use thereof |
| 02/17/2011 | US20110039324 Compositions and methods for enhancing apoptosis |
| 02/17/2011 | US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 02/17/2011 | US20110038894 Immunogenic Peptides of Tumor Associated Antigen L6 and Uses Thereof in Cancer Therapy |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038883 He4 monoclonal antibodies and methods for their use |
| 02/17/2011 | US20110038879 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 02/17/2011 | CA2770018A1 Novel peptide and use thereof |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/16/2011 | EP2283031A2 Lyme disease vaccine |
| 02/16/2011 | EP2283030A1 Pepstatin a derivatives |
| 02/16/2011 | EP2283029A1 Peptides |
| 02/16/2011 | EP1931696B1 Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
| 02/16/2011 | EP1466178B1 Screening methods for superoxide dismutase (sod)-inhibitors |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | CN101977933A Biomarkers |
| 02/16/2011 | CN101974076A Cyclic peptide for inhibiting cell proliferation and blood vessel hyperplasia induced by basic fibroblast growth factors |
| 02/16/2011 | CN101974075A Method for extracting polymyxin B and E from fermentation technique culture |
| 02/16/2011 | CN101974074A Application of alpha-fodrin polypeptide IgA antibody resistant measurement in sicca syndrome diagnosis |
| 02/16/2011 | CN101974073A Anti-inflammatory hexapeptide |
| 02/16/2011 | CN101974072A Escherichia coli TolC antigen as well as antibody and application thereof |
| 02/16/2011 | CN101974071A Insulin B chain HLA-A*0201 restrictive CTL epitope modified peptide ligand and acquisition method and application thereof |
| 02/16/2011 | CN101096381B Blood group A antigen epitope mimic peptide and its screening method |
| 02/15/2011 | US7888472 Optimized multi-epitope constructs and uses thereof |
| 02/15/2011 | US7888460 a mutant gliadin protein with the mutation in the epitope 62PQPQLPY68, or a fragment of such mutant protein (non-glidin sequence), decreases the ability of the epitope to induce a Tcell or antibody response |
| 02/15/2011 | US7888291 Substrates and assays for β-secretase |
| 02/15/2011 | US7888133 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 02/15/2011 | CA2471723C Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2325937C Peptide turn mimetics |
| 02/15/2011 | CA2189691C Novel tetrapeptides, their preparation and use |
| 02/15/2011 | CA2074370C Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 02/10/2011 | WO2011017132A2 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 02/10/2011 | WO2011015628A1 Novel antipathogenic peptides |
| 02/10/2011 | WO2011014990A1 Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof |
| 02/10/2011 | US20110035846 Transcriptional repressor peptides and genes for the same |
| 02/10/2011 | US20110034670 Bisubstrate inhibitors of protein kinases as therapeutic agents |
| 02/10/2011 | US20110034395 Compositions and methods of inhibiting apoptosis |
| 02/10/2011 | US20110034390 Peptides, compositions, and uses thereof |
| 02/10/2011 | US20110034387 Polypeptide inhibiting angiogenesis and application thereof |
| 02/10/2011 | US20110033892 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 02/10/2011 | US20110033874 Biomarkers |
| 02/10/2011 | US20110033518 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| 02/10/2011 | US20110033487 Vaccines and diagnostics for the ehrlichioses |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033380 Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 02/10/2011 | CA2768748A1 Novel antipathogenic peptides |
| 02/09/2011 | EP2281580A2 Labeled gastrin releasing peptides (GRP) |
| 02/09/2011 | EP2281574A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 02/09/2011 | EP2280994A1 Restoration of estrogen receptor-alpha activity |
| 02/09/2011 | EP2280989A2 Cyclosporin analogs and their use in the treatment of hcv infections |
| 02/09/2011 | EP2280988A2 Angiogenic peptide |
| 02/09/2011 | EP2137209B1 Compounds for the diagnosis of diseases associated with vcam expression |
| 02/09/2011 | EP2057184B1 Cyclic angiotensin analogs |